Who owns the IP
The organizations most actively patenting around this compound, ranked by referenced patent volume.
| # | Assignee | Patents |
|---|---|---|
| 1 | Roche Holding AG | 12 |
| 2 | Sinochem Holdings Corp Ltd | 8 |
| 3 | Amgen Inc | 7 |
| 4 | German Cancer Research Center | 5 |
| 5 | Hebrew University of Jerusalem | 5 |
| 6 | Novartis AG | 5 |
| 7 | Hadassah Medical Organization | 4 |
| 8 | Lonza Group AG | 4 |
| 9 | Massachusetts Institute of Technology | 4 |
| 10 | Asahi Kasei Corp | 3 |
Explore the full landscape
This preview shows the leading assignees. Cypris reveals the full ownership landscape - every filing entity, filing trends, and portfolio momentum.
Visit CyprisWhere innovation is concentrated
Patent classifications ranked by volume reveal the technical domains with the most active filing.
| # | Code | Area | Patents |
|---|---|---|---|
| 1 | C12N | Microorganisms, enzymes | 79 |
| 2 | A61K | Medicinal preparations | 43 |
| 3 | A61P | Therapeutic activity (drug indications) | 42 |
| 4 | C12Y | Enzyme nomenclature (EC numbers) | 36 |
| 5 | C12P | Fermentation, enzyme processes | 26 |
| 6 | C12Q | Measuring/testing involving enzymes | 26 |
| 7 | C07K | Peptides | 25 |
| 8 | G01N | Investigating / analysing materials | 21 |
| 9 | Y02E | Climate change mitigation: energy | 12 |
| 10 | C07D | Heterocyclic compounds | 11 |
AI mapped opportunity space
This preview shows where patent activity concentrates. Cypris maps the full classification landscape to surface technical whitespace and IP headroom.
See Cypris in actionRepresentative patents
The filings that best characterise the patent activity around this compound, most-referenced first.
| Title | Year | Assignee | Cited by |
|---|---|---|---|
| BI-FUNCTIONAL COMPLEXES AND METHODS FOR MAKING AND USING SUCH COMPLEXES | 2011 | Amgen Inc | 116 |
| POLYCOMB-ASSOCIATED NON-CODING RNAS | 2012 | Mass General Brigham Inc | 96 |
| Substituted 3-azabicyclo [3.1.0] hexanes as ketohexokinase inhibitors | 2018 | Pfizer Inc | 32 |
| 2.2-DIFLUOROPROPIONAMIDE DERIVATIVES OF BARDOXOLONE METHYL, POLYMORPHIC FORMS AND METHODS OF USE THEREOF | 2013 | Biogen Inc | 46 |
| PREVENTION OF DISULFIDE BOND REDUCTION DURING RECOMBINANT PRODUCTION OF POLYPEPTIDES | 2009 | Roche Holding AG | 58 |
Who's driving the science
The most-published authors working with this compound, alongside their primary affiliations.
| # | Author | Affiliation | Papers |
|---|---|---|---|
| 1 | Paul M. Stewart | University of Birmingham | 20 |
| 2 | Elizabeth A. Walker | University of Birmingham | 15 |
| 3 | Gareth G. Lavery | University of Birmingham | 13 |
| 4 | Angelo Benedetti | University of Siena | 11 |
| 5 | Alex Odermatt | University of Basel | 10 |
| 6 | Perrin C. White | The University of Texas Southwestern Medical Center | 9 |
| 7 | Silvia Senesi | University of Siena | 8 |
| 8 | Rosella Fulceri | University of Siena | 8 |
| 9 | Gábor Bánhegyi | Semmelweis University | 8 |
| 10 | Miklós Csala | Semmelweis University | 6 |
Research leaders
This preview lists the top authors. Cypris surfaces the full researcher landscape, their affiliations, and how scientific influence is shifting.
See Cypris in actionThe literature that defines it
The most-cited papers anchoring the scientific record for this compound.
| Title | Year | Cited by | Topic |
|---|---|---|---|
| 11β-Hydroxysteroid Dehydrogenase Type 1: A Tissue-Specific Regulator of Glucocorticoid Response | 2004 | 975 | Hormonal Regulation and Hypertension |
| Mutations in the genes encoding 11β-hydroxysteroid dehydrogenase type 1 and hexose-6-phosphate dehydrogenase interact to cause cortisone reductase deficiency | 2003 | 286 | Hormonal Regulation and Hypertension |
| Hexose‐6‐phosphate dehydrogenase determines the reaction direction of 11β‐hydroxysteroid dehydrogenase type 1 as an oxoreductase | 2004 | 208 | Ion Transport and Channel Regulation |
| Hexose-6-phosphate Dehydrogenase Knock-out Mice Lack 11β-Hydroxysteroid Dehydrogenase Type 1-mediated Glucocorticoid Generation | 2005 | 207 | Hormonal Regulation and Hypertension |
| Cooperativity between 11β-Hydroxysteroid Dehydrogenase Type 1 and Hexose-6-phosphate Dehydrogenase in the Lumen of the Endoplasmic Reticulum | 2004 | 168 | Hormonal Regulation and Hypertension |
Frequently asked questions
Common questions about this compound's patent and research landscape, answered from the underlying data.
What is the molecular formula and weight of 1-O-Phosphonohex-2-ulose?
Which organizations hold the most patents related to this compound?
What is the trend in patent filings for this compound in recent years?
What are the main research topics associated with this compound?
Which patent classifications are most relevant to inventions involving this compound?